Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.23 new
Vol. 5, Issue 5 (2016)

Could really systemic inflammatory markers be predictors of COPD Progression

Author(s):
BO Basina, GV Kondrateva
Abstract:
Inflammatory biomarkers are considered by modern researchers as one of the best markers of effectiveness of inhaled corticosteroids (ICS) at patients with COPD, but there are a few studies about their prediction opportunity for COPD progression. The study is devoted to study of the diagnostic value of some markers of systemic inflammation (CRP, fibrinogen, MMP-2 and -9, hyaluronic acid (HA) at patients with COPD, there role as predictors of COPD progression. It was determined that determination of dynamic levels of such marker of systemic inflammation as MMP-2, CRP, HA can be used as parameters for further evaluation of the clinical stability of patients during their long-term follow-up. Significant decreasing of inflammatory markers shows the adequacy of anti-inflammatory therapy of patients with COPD regardless of changes in lung function dynamic disorders.
Pages: 91-93  |  1006 Views  15 Downloads
How to cite this article:
BO Basina, GV Kondrateva. Could really systemic inflammatory markers be predictors of COPD Progression. Pharma Innovation 2016;5(5):91-93.
The Pharma Innovation Journal